Latest filing published 09 Nov 2016 for REJUVEL BIO-SCIENCES, INC., €18k.
Insider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -50.0%Entry US$0.00 · Close at T+365 US$0.00
- -98.0%Entry US$0.00 · Close at T+365 US$0.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Charles J. Scimeca: trading record in brief
Charles J. Scimeca has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Rejuvel Bio-Sciences, Inc., Corporate Equity Investments, Inc. and Quetzal Capital I Inc. The record holds 13 filings, for trades running from 14 March 2007 to 1 November 2016.
The open-market side counts 6 purchases for €549k alongside 6 sales for €84k. Netting one side against the other leaves €465k of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2016 to date brings 5 purchases and 2 sales.
The median purchase comes to €46k.
The latest filing, published on 9 November 2016, reports an open-market purchase of €18k in Rejuvel Bio-Sciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Charles J. Scimeca
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,896,552 shares@ US$0.0029PREFERRED SERIES CSEC:0001469709-16-000940:1Canonical exit: 27 Dec 2016 (T+90)
- 330,000,000 shares@ US$0.001COMMON STOCKSEC:0001469709-16-000940:2Canonical exit: 30 Jan 2017 (T+90)
- 17,253 shares@ US$0.00020.0% of flowPREFERRED SERIES ASEC:0001469709-16-000940:0Canonical exit: 27 Dec 2016 (T+90)
- 2,468,000 shares@ US$0.00060.9% of flowCOMMON STOCKSEC:0001469709-16-000801:0
- 4,675,000 shares@ US$0.0146COMMON STOCKSEC:0001469709-16-000714:0
- 111,607 shares@ US$0.1792PREFERRED SERIES CSEC:0001469709-16-000714:1Canonical exit: 26 May 2016 (T+90)
- 15,000 shares@ US$10.00100.0% of flowSERIES A PREFERREDSEC:0001469709-16-000670:0Canonical exit: 26 Apr 2016 (T+90)
- 3,000,000 shares@ US$0.001COMMON STOCKSEC:0001469709-14-000200:0
- 1,700,000 shares@ US$0.001COMMON STOCKSEC:0001469709-14-000200:1
- 100,000 shares@ US$0.001COMMON STOCKSEC:0001469709-14-000200:2
- 101,800,000 shares@ US$0.001Common StockSEC:0001507085-11-000008:0Canonical exit: 18 Jan 2012 (T+90)
- 1,999,000 shares@ US$0.011Common Stock, par value $0.001 per shareSEC:0001108017-09-000127:0
- 0COMMON STOCKSEC:0001108017-07-000163:0
13 of 13 declarations